Yu Chen-Ming 4
4 · Sagent Pharmaceuticals, Inc. · Filed Sep 11, 2012
Insider Transaction Report
Form 4
Yu Chen-Ming
Director
Transactions
- Award
Stock Option to Buy
2012-09-07+105,000→ 105,000 totalExercise: $15.52Exp: 2022-09-07→ Common Stock (105,000 underlying)
Footnotes (1)
- [F1]The option vested with respect to 50,000 shares upon issuance. The option vests with respect to an additional 5,000 shares each month beginning on October 31, 2012.